Serum Institute of India
Serum Institute of India all set to manufacture Novavax’s COVID-19 vaccine Covovax, trial data demonstrates 90.4 overall efficacy
Adar Poonawalla, the CEO of SII, plans to launch Novavax's Covovax in India by September contingent upon the regulatory approvals
France President Emmanuel Macron slams Joe Biden administration for blocking vaccine raw material export to India
French President Emmanuel Macron took potshots at the Joe Biden administration for blocking export of Covod-19 raw materials.
Not just indemnity, Pfizer wants disputes over vaccine supply under jurisdiction of US courts only, Indian govt in dilemma
The indemnity clause protects the company (in this case Pfizer) from any financial liability in case of legal disputes.
Forced by circumstances, the Serum Institute of India had moved the Delhi High Court in June 2012 under section 9 of the Arbitration Act.
Fact-check: Has govt of India not placed any new orders for coronavirus vaccines since March 2021? Here are the facts
Detailed account of advance given for vaccines for both, COVISHIELD as well as COVAXIN and the number of doses received was put forth by the government of India.
India Today’s Rahul Kanwal backtracks after receiving a letter from Shiv Sena, had claimed party goons heckled SII CEO Adar Poonawalla
The anchor now claims that the hoodlums seen in the video sent to him belonged to a different political party and not the Shiv Sena.
Adar Poonawalla’s factory was gheraod by Shiv Sena goons demanding that they be given the vaccine first: Rahul Kanwal
CEO of the Serum Institute of India Adar Poonawalla has temporarily moved out after facing threats from the most powerful men in India
Adar Poonawalla says Covishied production is in full swing, will return to India in a few days after meeting in UK
Adar Poonawalla shared the latest update on his meeting with the stakeholders in the UK and production of Covishield.
Serum Institute CEO Adar Poonawalla hints at starting vaccine production outside India, says he temporarily moved to UK due to threats from the powerful
Adar Poonawalla said Serum Institute will start vaccine production in other countries as it struggles to meet supply commitments
Bharat Biotech reduces the price of Covaxin for state governments a day after Covishield price for states cut by SII
Bharat Biotech has announced that it is reducing the price of its Covid-19 vaccine Covaxin for the state governments to Rs 400 from Rs 600